Please login or register first to view this content.
Hematological Disorders Resource Center
Drug Monographs
Click on the subsection below to see prescribing information
NEWS & FEATURES
Tazverik Granted Accelerated Approval for Follicular Lymphoma
Blood Donors Will Get Results of Coronavirus Antibody Test, Red Cross Says
Biosimilar Nyvepria Gets FDA Approval
FDA Grants Orphan Drug Status to Mitapivat for Thalassemia
Mepolizumab Gets Priority Review for Hypereosinophilic Syndrome
Ferriprox Twice-a-Day Tablet Dosing Approved for Transfusional Iron Overload Due to Thalassemia Syndromes
Sutimlimab Under Review for Hemolysis in Cold Agglutinin Disease
Successful Management of Severe COVID-19 in Otherwise Healthy Pediatric Patient
Vadadustat Noninferior to Darbepoetin Alfa for Anemia in Patients With Dialysis-Dependent CKD
Lokelma Labeling Updated With Dosing for Hyperkalemia in Dialysis-Dependent ESRD
Novel Pyruvate Kinase Activator Gets Orphan Drug Status for Sickle Cell Disease
Convalescent Plasma Treatment Promising in Severe COVID-19
FDA Approves Reblozyl for Anemia in Patients With Myelodysplastic Syndromes
FDA Updates Guidance on Blood Donation to Increase Supply During COVID-19 Pandemic
FDA Approves Sevenfact for Hemophilia A or B With Inhibitors
FDA Grants First Approval of Convalescent Plasma Therapy in COVID-19 Patient
Triferic AVNU Approved for Iron Replacement and Hemoglobin Maintenance in Dialysis Patients
Phytonadione Injectable Emulsion Ampules Recalled Following Reports of Glass Injuries